The Millennium Challenge Corporation (MCC) and Global Health
This fact sheet describes the functions, governance, funding, and approach of the Millennium Challenge Corporation (MCC), with a particular focus on MCC's engagement in global health.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This fact sheet describes the functions, governance, funding, and approach of the Millennium Challenge Corporation (MCC), with a particular focus on MCC's engagement in global health.
This Policy Insight outlines eight questions that are likely to shape the U.S. global health response in the last two years of the current presidential term and beyond.
The FY15 Omnibus Appropriations Act contains $5.4 billion in emergency funding to address the Ebola crisis – a significant increase in total U.S. support for global health. Aside from the additional funding for Ebola, global health funding remained essentially flat at $9.2 billion, according to a new Kaiser Family Foundation funding analysis.
On June 26, the Kaiser Family Foundation held a briefing examining the role and policies of the U.S. government and faith-based organizations in helping children orphaned or made vulnerable by the AIDS epidemic.
In this Think Global opinion piece, Jennifer Kates and Kellie Moss discuss what could happen if the United States’ signature initiative on global health is not reauthorized.
This analysis examines PEPFAR spending and HIV viral suppression rates in 22 countries from 2018–2023 to help identify which investments most effectively drive HIV outcomes and inform future directions.
This policy watch provides an overview of the current debate and key questions related to abortion surrounding the fourth reauthorization of PEPFAR.
This issue brief identifies options and issues for PEPFAR to consider should it institute a new co-financing policy to encourage increased domestic resource mobilization from countries.
The news today about the efficacy of a new long-acting injectable PrEP, the second such breakthrough announcement in recent months, is nothing short of groundbreaking.
In this viewpoint article in the Journal of the International AIDS Society, KFF's Jennifer Kates and co-authors Brian Honermann and Gregorio Millett of amfAR explore the implications of shifts in the global economic and political environment for the future of PEPFAR, the U.S government's global HIV program created under President George W. Bush and credited with changing the trajectory of the global HIV/AIDS pandemic.
© 2026 KFF